An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells
Cancer Lett. 2021 Mar 31;501:124-132. doi: 10.1016/j.canlet.2020.12.022. Epub 2020 Dec 19. Gang Zhou 1, Sarah Da Won Bae 1, Romario Nguyen 1, Xiaoqi Huo 1, Shuanglin Han 1, Zhiqiang Zhang 2, Lionel Hebbard 3, Wei Duan 4, Mohammed Eslam 1, Christopher Liddle 1, Lawrence Yuen 5, Vincent Lam 5, Liang Qiao 6, Jacob George 7 PMID: 33352247 DOI: 10.1016/j.canlet.2020.12.022 Abstract Liver cancer has no effective therapies, hence a poor survival. Cancer stem-like cells not only contribute to cancer initiation and progression, but also to …